InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback